CHA Biotech subsidiary Matica Biolabs signed a contract to manufacture medical developer TiCARos' new CAR-T cancer therapy drugs for clinical trials, the companies said Wednesday.

Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.

Merck spent $10bn on lung disease-focused biotech Verona Pharma in July, its biggest acquisition in two years, amid concerns ...

Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US ...

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology ...

Dow Jones Top Company Headlines at 5 PM ET: JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks May Have to Keep Up. | Nvidia ... JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks ...

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Photoactive nanomaterials represent a dynamic and rapidly evolving area within nanobiotechnology, offering unique opportunities to manipulate cellular and ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice.

For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business ...

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...